CSRC defers a vote on Medisan Pharmaceutical’s IPO

On 26 April, 2017, the China Securities Regulatory Commission (CSRC) deferred a vote on the initial public offering (IPO) of Harbin Medisan Pharmaceutical Co., Ltd. (Medisan Pharmaceutical), and no questions have been made.Medisan Pharmaceutical is e...

Amino Acids China E-News 201705

www.cnchemicals.com